Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/11436
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSh.Ya.Zakirkhojaev-
dc.contributor.authorM.Kh.Talibdzhanova-
dc.date.accessioned2024-06-15T04:43:30Z-
dc.date.available2024-06-15T04:43:30Z-
dc.date.issued2024-
dc.identifier.issn2795-7365-
dc.identifier.urihttp://repository.tma.uz/xmlui/handle/1/11436-
dc.description.abstractScientific research data on Covid-19 shows that 14-53% of patients have signs of mild-tomoderate liver damage: increased levels of aminotransferases, hypoproteinemia, increased prothrombin time. Severity of Covid-19 cases are correlated with extensity of liver damage. On the other hand, prior to infection, active liver disease increased the severity of the infection. SARS-Cov-2 has a feature of direct damage of the hepatocytes which is explained by presence of angiotensin converting enzyme 2 receptors in the cholangiocytes. Patients with chronic diffuse and advanced liver diseases are at higher risk of infection due to cirrhosis affect on immune mechanisms.en_US
dc.language.isoenen_US
dc.publisherEurasian Research Bulletinen_US
dc.subjectchronic hepatitis, Covid-19, damage, inflammationen_US
dc.titleAnalysis Of Immunometabolic Changes in Patients With Chronic Liver Disease With Covid-19en_US
dc.typeArticleen_US
Appears in Collections:Thesis, Articles

Files in This Item:
File Description SizeFormat 
9.3 (14).pdf272.41 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.